Michael Robert A. 4
4 · AbbVie Inc. · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
AbbVie (ABBV) CEO Michael Robert A. Sells 36,523 Shares (Tax Withholding)
What Happened
- Michael Robert A., Chairman of the Board and CEO of AbbVie (ABBV), reported a disposition of 36,523 shares on 2026-02-27 to satisfy an exercise price or tax liability. The shares were valued at $232.08 each, for a total of approximately $8,476,258.
- This transaction is reported as tax withholding (code F), meaning shares were surrendered/withheld to cover tax obligations — a routine administrative action rather than an open-market sale intended as investment signaling.
Key Details
- Transaction date: 2026-02-27; Filed with the SEC: 2026-03-03 (appears to be filed within the usual 2-business-day window).
- Price per share: $232.08; Shares involved: 36,523; Total value: ~$8,476,258.
- Transaction code: F — Payment of exercise price or tax liability (sell-to-cover/withholding).
- Post-transaction shares owned: Not provided in the data you supplied (not disclosed here).
- No indication in this report that shares were sold on the open market; this was a tax-withholding disposition.
Context
- Tax-withholding dispositions are common when stock grants vest or options are exercised; they are administrative and don’t necessarily reflect the insider’s view on the company’s stock. For retail investors, purchases by insiders tend to be more informative than routine withholding or gift-related dispositions.
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Michael Robert A.
DirectorCHAIRMAN OF THE BOARD AND CEO
Transactions
- Tax Payment
Common Stock, $0.01 par value
2026-02-27$232.08/sh−36,523$8,476,258→ 178,737 total
Signature
/s/ T.O. Odutayo, Attorney-in-Fact for Robert A. Michael|2026-03-03